|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
N/A
|
National Institutes of Health
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
5P30CA008748-52
|
$12,352,942
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Dana-Farber/Harvard Cancer Center
|
5P30CA006516-53
|
$11,504,298
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA015704-43
|
$9,559,285
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-42
|
$7,716,753
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
5P30CA021765-39
|
$6,063,271
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
5P30CA016058-42
|
$4,798,608
|
POLLOCK, RAPHAEL
|
OHIO STATE UNIVERSITY
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,462,501
|
Glod, John
|
CCR (NCI)
|
|
Metabolic reprogramming of tumor microenvironment to maximize immunotherapy for pediatric cancers
|
1U01CA232488-01
|
$3,370,657
|
WANG, RUONING
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Center for pediatric tumor cell atlas
|
1U2CCA233285-01
|
$2,560,774
|
TAN, KAI
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
5P30CA051008-25
|
$2,306,055
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Combinations of Synergistic Bispecific Human Antibodies: A Novel Strategy for the Treatment of Neuroblastoma
|
1U01CA232490-01
|
$2,200,000
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
|
5P01CA217959-02
|
$2,171,238
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
University of Hawaii Cancer Center CCSG
|
2P30CA071789-18
|
$1,913,800
|
HOLCOMBE, RANDALL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Development of new antibody-based cancer therapies
|
ZIA BC 010891
|
$1,311,617
|
Ho, Mitchell
|
CCR (NCI)
|
|
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
|
5R35CA220500-02
|
$1,032,000
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
|
5U01CA217864-02
|
$1,010,431
|
WEISS, WILLIAM
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$756,068
|
Thiele, Carol
|
CCR (NCI)
|
|
PARP-1 as a novel target for alpha-particle therapy in high-risk Neuroblastoma
|
1R01CA219006-01A1
|
$652,362
|
PRYMA, DANIEL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Development of the first-in-class novel dual PI-3K/BRD4 inhibitor SF2523
|
5R42CA192656-03
|
$647,711
|
MORALES, GUILLERMO
|
SIGNALRX PHARMACEUTICALS, INC.
|
|
Research and Development of Effective Therapies for Patients with Rare Tumors
|
ZIA SC 010354
|
$646,556
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways
|
5R01CA057138-27
|
$635,460
|
EISENMAN, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma
|
1R01CA214912-01A1
|
$629,914
|
DUBOIS, STEVEN
|
DANA-FARBER CANCER INST
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Role of LMO1 in Neuroblastoma Initiation and Maintenance
|
5R01CA180692-04
|
$606,838
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$602,021
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$587,337
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Genomic and functional characterization of a panel of neuroblastoma patient-derived xenografts and cell lines
|
1R01CA221957-01
|
$553,437
|
REYNOLDS, CHARLES
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$526,810
|
Khan, Javed
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA008748-52S1
|
$485,648
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Exosomes in tumor cell-mesenchymal stromal cell interaction
|
5R01CA207983-02
|
$449,691
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S1
|
$445,796
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
|
1R01CA227671-01A1
|
$431,631
|
ZHENG, PAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Cancer immunotherapy
|
ZIA BC 011803
|
$421,442
|
Ruppin, Eytan
|
CCR (NCI)
|
|
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers
|
1U01CA224766-01
|
$418,320
|
HEDRICK, CATHERINE
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma
|
5R01CA148688-07
|
$413,844
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
Development of small molecules to target KDM4B
|
1R01CA229739-01
|
$410,606
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Transcriptional CDKs as therapeutic targets in MYC-dependent cancers
|
5R01CA197336-03
|
$407,748
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$407,114
|
Thiele, Carol
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|